Disruption of traditional health care is inevitable and poses a central challenge for health care governance. While the size and complexity of the health care industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for health care governance.
Disruption of traditional health care is inevitable and poses a central challenge for health care governance. While the size and complexity of the health care industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for health care governance.
Disruption of traditional health care is inevitable and poses a central challenge for health care governance. While the size and complexity of the health care industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for health care governance.
Disruption of traditional health care is inevitable and poses a central challenge for health care governance. While the size and complexity of the health care industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for health care governance.
Michael Peregrine represents corporations in all areas of corporate governance law, and is recognized as one of the leading national practitioners and thought leaders in corporate governance. Read more.
Ken Kaufman is Chair of Kaufman Hall. He provides health care organizations with counsel and guidance in areas including strategy, finance, financial and capital planning, mergers and acquisitions, and partnerships. Read more.
Business disruption is emerging as one of the most compelling corporate governance challenges for health care organizations. Through the development and oversight of a strategic governance and risk management plan, boards can make an extraordinary difference in responding to disruptive threats from innovative, non-traditional competitors.
As the forces of business disruption breach the health care sector, providers must adopt responsive strategies in order to guide their organizations through the challenge of meeting consumer demands for more convenient, affordable health care through significant technological investments, while balancing their fiduciary duty of managing costs.
Disruption in health care is a certainty. The four largest organizations in the world by market cap are closely watching this space and some are wading in. If you are part of the strategic planning or finance committees, you need to ensure that you understand and are planning for the threat that these and other players pose to the industry status quo.
Legal Notices | Privacy Policy
Attorney Advertising
